Landlocked developing countries (LLDCs) vs Mexico: Proportion of the target population who received the final dose
Landlocked developing countries (LLDCs)
44.0%
in 2024
Mexico
82.0%
in 2024
Landlocked developing countries (LLDCs) rank
17th
Mexico rank
20th
Proportion of the target population who received the final dose over time
- Landlocked developing countries (LLDCs)
- Mexico
How they compare
Mexico currently reports 82.0% against 44.0% in Landlocked developing countries (LLDCs), a difference of 38.0%.
That makes Mexico's figure about 1.9 times Landlocked developing countries (LLDCs)'s.
The two have swapped places 2 times across 13 shared years of data; in 2012 it was Mexico ahead.
Landlocked developing countries (LLDCs) ranks 17th and Mexico ranks 20th of 34 groups.
Mexico has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Landlocked developing countries (LLDCs) | Mexico | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 6.5% | 93.4% | 86.9% | Mexico |
| 2020s | 28.2% | 50.0% | 21.8% | Mexico |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Landlocked developing countries (LLDCs) or Mexico?
- Mexico, at 82.0% against 44.0% in Landlocked developing countries (LLDCs) as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Landlocked developing countries (LLDCs) and Mexico?
- 38.0%, with Mexico ahead.
- How many years of comparable data are there for Landlocked developing countries (LLDCs) and Mexico?
- 13 years are reported by both, from 2012 to 2024.
- How do Landlocked developing countries (LLDCs) and Mexico rank globally for proportion of the target population who received the final dose of?
- Landlocked developing countries (LLDCs) ranks 17th and Mexico ranks 20th of 34 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.